Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RADIANCE 2: Torcetrapib/Atorvastatin in Mixed Hyperlipidemia
NCT00134238Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Nov 2003
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of torcetrapib in mixed hyperlipidemia, sponsored by Pfizer. Started Nov 2003; status: terminated.
02
Drugs
torcetrapib
03
Conditions
mixed hyperlipidemia
Beyond the preview
Go deeper on NCT00134238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134238.